These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
167 related items for PubMed ID: 31820985
1. Design, Synthesis, and Biological Evaluation of Amidobenzimidazole Derivatives as Stimulator of Interferon Genes (STING) Receptor Agonists. Xi Q, Wang M, Jia W, Yang M, Hu J, Jin J, Chen X, Yin D, Wang X. J Med Chem; 2020 Jan 09; 63(1):260-282. PubMed ID: 31820985 [Abstract] [Full Text] [Related]
2. Structure-Activity Relationship Study of Amidobenzimidazole Analogues Leading to Potent and Systemically Administrable Stimulator of Interferon Gene (STING) Agonists. Song Z, Wang X, Zhang Y, Gu W, Shen A, Ding C, Li H, Xiao R, Geng M, Xie Z, Zhang A. J Med Chem; 2021 Feb 11; 64(3):1649-1669. PubMed ID: 33470814 [Abstract] [Full Text] [Related]
3. Structure-activity relationship study of amidobenzimidazole derivatives as stimulator of interferon genes (STING) agonists. Liu X, Wang M, Yang M, Sun H, Wang B, Pan X, Chen X, Jin J, Wang X. Eur J Med Chem; 2023 Jan 15; 246():114943. PubMed ID: 36462438 [Abstract] [Full Text] [Related]
4. Design of amidobenzimidazole STING receptor agonists with systemic activity. Ramanjulu JM, Pesiridis GS, Yang J, Concha N, Singhaus R, Zhang SY, Tran JL, Moore P, Lehmann S, Eberl HC, Muelbaier M, Schneck JL, Clemens J, Adam M, Mehlmann J, Romano J, Morales A, Kang J, Leister L, Graybill TL, Charnley AK, Ye G, Nevins N, Behnia K, Wolf AI, Kasparcova V, Nurse K, Wang L, Puhl AC, Li Y, Klein M, Hopson CB, Guss J, Bantscheff M, Bergamini G, Reilly MA, Lian Y, Duffy KJ, Adams J, Foley KP, Gough PJ, Marquis RW, Smothers J, Hoos A, Bertin J. Nature; 2018 Dec 15; 564(7736):439-443. PubMed ID: 30405246 [Abstract] [Full Text] [Related]
5. Discovery of triazoloquinoxaline as novel STING agonists via structure-based virtual screening. Hou H, Yang R, Liu X, Wu X, Zhang S, Chen K, Zheng M. Bioorg Chem; 2020 Jul 15; 100():103958. PubMed ID: 32470762 [Abstract] [Full Text] [Related]
6. Development of Orally Bioavailable Amidobenzimidazole Analogues Targeting Stimulator of Interferon Gene (STING) Receptor. Chen NN, Zhang H, Zhu QS, Zeng T, Dai W, Zhou YL, Xin GF, Wu BD, Gong SJ, Jiang ZY, You QD, Xu XL. J Med Chem; 2023 Apr 27; 66(8):5584-5610. PubMed ID: 37027512 [Abstract] [Full Text] [Related]
7. Agonist of stimulator of interferon genes as antitumor agents: a patent review (2008-2020). Chen NN, Zhang H, You QD, Xu XL. Expert Opin Ther Pat; 2021 Jun 27; 31(6):563-584. PubMed ID: 33459063 [Abstract] [Full Text] [Related]
8. Design, Synthesis and Biological Evaluation of (2',5' and 3'5'-Linked) cGAMP Analogs that Activate Stimulator of Interferon Genes (STING). Xie X, Liu J, Wang X. Molecules; 2020 Nov 12; 25(22):. PubMed ID: 33198423 [Abstract] [Full Text] [Related]
9. Computational study on new natural compound agonists of stimulator of interferon genes (STING). Zhong S, Li W, Bai Y, Wu B, Wang X, Jiang S, Zhao Y, Ren J, Li H, Jin R. PLoS One; 2019 Nov 12; 14(5):e0216678. PubMed ID: 31120925 [Abstract] [Full Text] [Related]
10. STING Signaling in Cancer Cells: Important or Not? Sokolowska O, Nowis D. Arch Immunol Ther Exp (Warsz); 2018 Apr 12; 66(2):125-132. PubMed ID: 28748479 [Abstract] [Full Text] [Related]
11. Identification of Novel Carbocyclic Pyrimidine Cyclic Dinucleotide STING Agonists for Antitumor Immunotherapy Using Systemic Intravenous Route. Vyskocil S, Cardin D, Ciavarri J, Conlon J, Cullis C, England D, Gershman R, Gigstad K, Gipson K, Gould A, Greenspan P, Griffin R, Gulavita N, Harrison S, Hu Z, Hu Y, Hata A, Huang J, Huang SC, Janowick D, Jones M, Kolev V, Langston SP, Lee HM, Li G, Lok D, Ma L, Mai D, Malley J, Matsuda A, Mizutani H, Mizutani M, Molchanova N, Nunes E, Pusalkar S, Renou C, Rowland S, Sato Y, Shaw M, Shen L, Shi Z, Skene R, Soucy F, Stroud S, Xu H, Xu T, Abu-Yousif AO, Zhang J. J Med Chem; 2021 May 27; 64(10):6902-6923. PubMed ID: 34000802 [Abstract] [Full Text] [Related]
12. Development of Potent Immune Modulators Targeting Stimulator of Interferon Genes Receptor. Jeon MJ, Lee H, Lee J, Baek SY, Lee D, Jo S, Lee JY, Kang M, Jung HR, Han SB, Kim NJ, Lee S, Kim H. J Med Chem; 2022 Apr 14; 65(7):5407-5432. PubMed ID: 35315650 [No Abstract] [Full Text] [Related]
13. TNFα and Radioresistant Stromal Cells Are Essential for Therapeutic Efficacy of Cyclic Dinucleotide STING Agonists in Nonimmunogenic Tumors. Francica BJ, Ghasemzadeh A, Desbien AL, Theodros D, Sivick KE, Reiner GL, Hix Glickman L, Marciscano AE, Sharabi AB, Leong ML, McWhirter SM, Dubensky TW, Pardoll DM, Drake CG. Cancer Immunol Res; 2018 Apr 14; 6(4):422-433. PubMed ID: 29472271 [Abstract] [Full Text] [Related]
14. Binding of Duck Tembusu Virus Nonstructural Protein 2A to Duck STING Disrupts Induction of Its Signal Transduction Cascade To Inhibit Beta Interferon Induction. Zhang W, Jiang B, Zeng M, Duan Y, Wu Z, Wu Y, Wang T, Wang M, Jia R, Zhu D, Liu M, Zhao X, Yang Q, Wu Y, Zhang S, Liu Y, Zhang L, Yu Y, Pan L, Chen S, Cheng A. J Virol; 2020 Apr 16; 94(9):. PubMed ID: 32075929 [Abstract] [Full Text] [Related]
15. Discovery and Mechanistic Study of a Novel Human-Stimulator-of-Interferon-Genes Agonist. Zhang X, Liu B, Tang L, Su Q, Hwang N, Sehgal M, Cheng J, Ma J, Zhang X, Tan Y, Zhou Y, Duan Z, DeFilippis VR, Viswanathan U, Kulp J, Du Y, Guo JT, Chang J. ACS Infect Dis; 2019 Jul 12; 5(7):1139-1149. PubMed ID: 31060350 [Abstract] [Full Text] [Related]
18. STAT3 inhibition enhances CDN-induced STING signaling and antitumor immunity. Pei J, Zhang Y, Luo Q, Zheng W, Li W, Zeng X, Li Q, Quan J. Cancer Lett; 2019 May 28; 450():110-122. PubMed ID: 30790684 [Abstract] [Full Text] [Related]